BioCentury

5:24 AM, Jun 21, 2017
BC Extra  |  Financial News

Sigilon debuts with $23.5M series A

by Virginia Li

Sigilon Therapeutics Inc. (Cambridge, Mass.) emerged from Flagship Pioneering's VentureLabs incubator with $23.5 million in series A funding...

Read the full 68 word article

© 2019 BioCentury Inc. All Rights Reserved.    Terms & Conditions | Privacy Policy